These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 15342952
1. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Sawada H, Takami K, Asahi S. Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952 [Abstract] [Full Text] [Related]
2. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Nioi P, Perry BK, Wang EJ, Gu YZ, Snyder RD. Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588 [Abstract] [Full Text] [Related]
3. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Atienzar F, Gerets H, Dufrane S, Tilmant K, Cornet M, Dhalluin S, Ruty B, Rose G, Canning M. Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557 [Abstract] [Full Text] [Related]
4. Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay. Sawada H, Taniguchi K, Takami K. Toxicol In Vitro; 2006 Dec; 20(8):1506-13. PubMed ID: 16919414 [Abstract] [Full Text] [Related]
5. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase. Natalie M, Margino S, Erik H, Annelieke P, Geert V, Philippe V. Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623 [Abstract] [Full Text] [Related]
7. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Lambert CB, Spire C, Claude N, Guillouzo A. Toxicol Appl Pharmacol; 2009 Feb 01; 234(3):345-60. PubMed ID: 19084549 [Abstract] [Full Text] [Related]
8. Drug-induced phospholipidosis. Anderson N, Borlak J. FEBS Lett; 2006 Oct 09; 580(23):5533-40. PubMed ID: 16979167 [Abstract] [Full Text] [Related]
9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Ann Surg Oncol; 2010 Mar 09; 17(3):923-32. PubMed ID: 19898900 [Abstract] [Full Text] [Related]
10. In vitro assays and biomarkers for drug-induced phospholipidosis. Monteith DK, Morgan RE, Halstead B. Expert Opin Drug Metab Toxicol; 2006 Oct 09; 2(5):687-96. PubMed ID: 17014389 [Abstract] [Full Text] [Related]
11. Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Hirode M, Ono A, Miyagishima T, Nagao T, Ohno Y, Urushidani T. Toxicol Appl Pharmacol; 2008 Jun 15; 229(3):290-9. PubMed ID: 18355885 [Abstract] [Full Text] [Related]
12. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver. Tilton SC, Gerwick LG, Hendricks JD, Rosato CS, Corley-Smith G, Givan SA, Bailey GS, Bayne CJ, Williams DE. Toxicol Sci; 2005 Dec 15; 88(2):319-30. PubMed ID: 16141433 [Abstract] [Full Text] [Related]
13. Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Lambert CB, Spire C, Renaud MP, Claude N, Guillouzo A. Toxicol In Vitro; 2009 Apr 15; 23(3):466-75. PubMed ID: 19159669 [Abstract] [Full Text] [Related]
14. Altered gene expression in human hepatoma HepG2 cells exposed to low-level 2,4-dichlorophenoxyacetic acid and potassium nitrate. Bharadwaj L, Dhami K, Schneberger D, Stevens M, Renaud C, Ali A. Toxicol In Vitro; 2005 Aug 15; 19(5):603-19. PubMed ID: 15878651 [Abstract] [Full Text] [Related]
15. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration. Yudate HT, Kai T, Aoki M, Minowa Y, Yamada T, Kimura T, Ono A, Yamada H, Ohno Y, Urushidani T. Toxicology; 2012 May 16; 295(1-3):1-7. PubMed ID: 22426296 [Abstract] [Full Text] [Related]
16. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP. Toxicol Sci; 2004 Feb 16; 77(2):249-57. PubMed ID: 14691202 [Abstract] [Full Text] [Related]
17. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats. Miyamoto S, Matsumoto A, Mori I, Horinouchi A. Toxicol Mech Methods; 2009 Oct 16; 19(8):477-85. PubMed ID: 19793005 [Abstract] [Full Text] [Related]
18. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP. Mesens N, Desmidt M, Verheyen GR, Starckx S, Damsch S, De Vries R, Verhemeldonck M, Van Gompel J, Lampo A, Lammens L. Toxicol Pathol; 2012 Apr 16; 40(3):491-503. PubMed ID: 22291062 [Abstract] [Full Text] [Related]
19. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages. McCloud CM, Beard TL, Kacew S, Reasor MJ. Exp Mol Pathol; 1995 Feb 16; 62(1):12-21. PubMed ID: 7556587 [Abstract] [Full Text] [Related]
20. Phospholipidosis induced by PPARγ signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone. Song M, Kim YJ, Ryu JC. Toxicol Sci; 2011 Mar 16; 120(1):98-108. PubMed ID: 21123845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]